Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- SCOTIndependent statistical analysis of Scleroderma: Cyclophosphamide or Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00114530).
- SCOUTS3Independent statistical analysis of Stroke and CPAP Outcome Study 3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06029959).
- SCP® Observational Study of the Knee: Complete Statistical AnalysisIndependent statistical analysis of SCP® Observational Study of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03110224).
- SCS-90Independent statistical analysis of Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees, 90-Day: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCT&DVTIndependent statistical analysis of Sickle Cell Trait and the Risk of Venous Thromboembolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01148940).
- Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SDFCIndependent statistical analysis of Olfactory Contributions to Sleep-dependent Food Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04179838).
- SDHDSIndependent statistical analysis of The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SDOHIndependent statistical analysis of Social Determinants of Health Screening and Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03661359).
- SDTTIndependent statistical analysis of Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05158179).
- SEAIRAIndependent statistical analysis of Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SEALIndependent statistical analysis of Use of Tachosil® for Lymph Sealing During Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01920958).
- SEAMLESSIndependent statistical analysis of A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SEARCHIndependent statistical analysis of Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo: Complete Statistical AnalysisIndependent statistical analysis of Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01203189).
- Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup: Complete Statistical AnalysisIndependent statistical analysis of Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup:…
- SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil – Fast Admin: Complete Statistical AnalysisIndependent statistical analysis of SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01262989).
- SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil – Fed Admin: Complete Statistical AnalysisIndependent statistical analysis of SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01330303).
- Sedentary Behavior Interrupted Randomized Controlled Trial (P2): Complete Statistical AnalysisIndependent statistical analysis of Sedentary Behavior Interrupted Randomized Controlled Trial (P2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03473145).
- SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation: Complete Statistical AnalysisIndependent statistical analysis of SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SEEK: Dissemination and Implementation: Complete Statistical AnalysisIndependent statistical analysis of SEEK: Dissemination and Implementation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03642327).
- SEJIndependent statistical analysis of Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03047473).
- SELECT-3Independent statistical analysis of Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence…
- SELECT-EARLYIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate: primary endpoint results, effect estimate…
- SELECT2Independent statistical analysis of SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD: Complete Statistical AnalysisIndependent statistical analysis of Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SELECTSUNRISEIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and…
- Self Cranial Electrical Stimulation (CES) for Pain in Older Adults With Knee Osteoarthritis (Self CES for Knee Pain): Complete Statistical AnalysisIndependent statistical analysis of Self Cranial Electrical Stimulation (CES) for Pain in Older Adults With Knee Osteoarthritis (Self CES for Knee Pain): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Self-Administered Interactive Exercise Program (Tele-Exergame): Complete Statistical AnalysisIndependent statistical analysis of Self-Administered Interactive Exercise Program (Tele-Exergame): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07072962).
- Self-management Intervention for Children With Chronic Medical Complexity: Pilot Feasibility Trial: Complete Statistical AnalysisIndependent statistical analysis of Self-management Intervention for Children With Chronic Medical Complexity: Pilot Feasibility Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Self-System Therapy for Older Adults With Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Self-System Therapy for Older Adults With Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04057196).
- Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma: Complete Statistical AnalysisIndependent statistical analysis of Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Semaglutide for Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Semaglutide for Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05520775).
- SENECAIndependent statistical analysis of Stem Cell Injection in Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02509156).
- Sensory Effects of Rapidly-Changing Magnetic Fields: Complete Statistical AnalysisIndependent statistical analysis of Sensory Effects of Rapidly-Changing Magnetic Fields: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01632800).
- Sensory Stimulation During CIMT: Complete Statistical AnalysisIndependent statistical analysis of Sensory Stimulation During CIMT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03558230).
- SensoryFLOIndependent statistical analysis of Effects of Acute Intermittent Hypoxia on Sensory Function in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.: Complete Statistical AnalysisIndependent statistical analysis of Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.: primary endpoint results, effect…
- SENTIOIndependent statistical analysis of Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sequential and Hybrid Therapies for H Pylori Infection: Complete Statistical AnalysisIndependent statistical analysis of Sequential and Hybrid Therapies for H Pylori Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01085786).
- Sequential Vaccinations in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Sequential Vaccinations in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00060528).
- SequoiaIndependent statistical analysis of Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SEQUOIA-HCMIndependent statistical analysis of Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM: primary endpoint results, effect estimate with confidence interval, sample-size…
- SERENA-2Independent statistical analysis of A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative…
- SERENEIndependent statistical analysis of Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy: primary endpoint results, effect…
- SERENITY IIIndependent statistical analysis of Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04276883).
- Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC): Complete Statistical AnalysisIndependent statistical analysis of Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04508725).